News
Moderna Inc. is in discussions with large drugmakers and financial firms to get funding for some late-stage vaccine trials as ...
First, let's back up a bit and take a look at the Moderna story, from the glory days of a few years ago to its troubles today ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
The Food and Drug Administration (FDA) has approved Moderna’s next-generation mRNA COVID-19 vaccine mNexspike ®.
From eligibility to dosage and future rollout, here’s what you need to know about the FDA’s latest vaccine approval.
The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic ...
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...
In this July 19, 2022, a vial of Moderna COVID-19 vaccine rests on a table at an inoculation station in Jackson, ...
Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results